BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10922055)

  • 1. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.
    Michienzi A; Cagnon L; Bahner I; Rossi JJ
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8955-60. PubMed ID: 10922055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The post-transcriptional regulator Rev of HIV: implications for its interaction with the nucleolar protein B23.
    Miyazaki Y; Nosaka T; Hatanaka M
    Biochimie; 1996; 78(11-12):1081-6. PubMed ID: 9150888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxicity of human immunodeficiency virus type 1 Rev: implications for its interaction with the nucleolar protein B23.
    Miyazaki Y; Takamatsu T; Nosaka T; Fujita S; Martin TE; Hatanaka M
    Exp Cell Res; 1995 Jul; 219(1):93-101. PubMed ID: 7628555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of HIV-1 RNA in mammalian nuclei.
    Zhang G; Zapp ML; Yan G; Green MR
    J Cell Biol; 1996 Oct; 135(1):9-18. PubMed ID: 8858159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
    Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
    Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
    Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
    PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention.
    D'Agostino DM; Ciminale V; Pavlakis GN; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1063-71. PubMed ID: 8554903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.
    Arizala JAC; Takahashi M; Burnett JC; Ouellet DL; Li H; Rossi JJ
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):961-981. PubMed ID: 29804468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
    Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
    Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rev protein of human immunodeficiency virus type 1 and cellular exportin 1 protein relocalize each other to a subnucleolar structure.
    Ristea S; Dobbelstein M; Roth J
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):857-65. PubMed ID: 10875611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular trafficking and interactions of the HIV-1 Tat protein.
    Stauber RH; Pavlakis GN
    Virology; 1998 Dec; 252(1):126-36. PubMed ID: 9875323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
    Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
    Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.
    Lo KM; Biasolo MA; Dehni G; Palú G; Haseltine WA
    Virology; 1992 Sep; 190(1):176-83. PubMed ID: 1529527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nucleolar TAR decoy inhibitor of HIV-1 replication.
    Michienzi A; Li S; Zaia JA; Rossi JJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14047-52. PubMed ID: 12376617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.
    Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ
    Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein.
    Dundr M; Leno GH; Hammarskjöld ML; Rekosh D; Helga-Maria C; Olson MO
    J Cell Sci; 1995 Aug; 108 ( Pt 8)():2811-23. PubMed ID: 7593322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.